HHS third most research intensive hospital in Canada
For the second consecutive year, Hamilton Health Sciences (HHS) has been ranked third in Canada for hospital-based research, as announced today by Research Infosource Inc.
In 2018, Hamilton Health Sciences research revenues were $195.8 million, a decrease of 5.4 percent as compared to the previous year. Fluctuation in research revenue relates to a variety of factors including study completion and funding from many sources. For example, in 2017, HHS had a 20 percent increase in research revenues.
“The consistently high placement of HHS among the top research hospitals in Canada is testament to the calibre of research conducted by our five research institutes in partnership with McMaster University,” said Dr. Salim Yusuf, chief scientist, Hamilton Health Sciences, distinguished professor of medicine at McMaster University and executive director, Population Health Research Institute.
“Our research continues to improve the prevention and treatment of patients globally with heart disease, stroke, diabetes, cancer, and the health of children and elderly and who undergo surgery,” added Dr. Yusuf.
Hamilton Health Sciences’ achievements in people-centred research has world-reaching impact with more than one million participants enrolled to date from across the six inhabited continents.
“Improving patient care through research is core to our mandate as an academic teaching hospital and our patients are often among the first to participate in ground-breaking research studies,” says Dr. Ted Scott, vice president of research and chief innovation officer at HHS. This ranking is testimony to the commitment and impact of Hamilton Health Sciences research leadership globally.”
Research Infosource Inc. is an independent, leading source of ranking information on research universities, corporations, hospitals and colleges in Canada. Each year, it releases results on the top 40 research hospitals in the country, based on total research revenue.
Learn more about research at HHS.